Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
06/2003
06/05/2003US20030105279 Aromatic and heteroaromatic acid halides for synthesizing polyamides
06/05/2003US20030105161 Analgesics; antiinflamamtory agents
06/05/2003US20030105143 Bactericides, antiseptics, cosmetics, cleaning compounds, enhaned oil recovery, papermaking
06/05/2003US20030105132 N-phenpropylcuclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
06/05/2003US20030105110 Novel compounds
06/05/2003US20030105100 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/05/2003US20030105092 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
06/05/2003US20030105091 Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
06/05/2003DE10207460C1 Column for concentration of phthalic anhydride, with vertical wall dividing first stage for removing low-boiling material and second stage for separating high-boiling material, has connection between sumps of both stages
06/05/2003CA2468706A1 Combination of an il-1/18 inhibitor with a tnf inhibitor for the treatment of inflammation
06/05/2003CA2468623A1 Preparation and use of gamma-butyrolactones as cross-linking agents
06/05/2003CA2468422A1 3-biphenyl-substituted-3-substituted-4-ketolactam and ketolactone and their utilization as pesticide
06/05/2003CA2468280A1 Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes
06/05/2003CA2467966A1 Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
06/05/2003CA2467665A1 2,w-diaminocarboxylic acid compounds
06/04/2003EP1315710A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315709A1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315708A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315500A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP0994111B1 Tetrahydrofuran derivatives
06/04/2003EP0964849B1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
06/04/2003EP0938712B1 System and method for remotely grouping contents of an action history stack
06/04/2003EP0882032B1 Process for the preparation of gamma-butyrolactone and the use thereof
06/04/2003EP0862545B1 Pesticide compounds, compositions and process for the preparation thereof
06/04/2003CN1422266A Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
06/04/2003CN1421443A Furan 4alpha-methylol polyhydro naphthalene compound and its synthesis and use
06/04/2003CN1110492C Prodrugs of aspartyl protease inhibitors
06/04/2003CN1110491C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
06/03/2003US6573395 Zinc complex with a chiral ligand, such as diethylzinc((S,S)-N-N'-ethylene-bis-(1-phenylethylamine))
06/03/2003US6573393 Method for producing L-ascorbic acid
06/03/2003US6573390 Muscle relaxant, hypotensive agent, respiratory system disorders, gastrointestinal disorders, fertility, incontinence, shock, antiinflammatory agents, immunology, bone disorders, antiproliferative agents
06/03/2003US6573388 Synthetic intermediates for the synthesis of HIV protease inhibitors and oligopeptide mimetics
06/03/2003US6573278 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
06/03/2003US6573266 Piperazine derivatives and their use as anti-inflammatory agents
06/03/2003CA2354880C Method for the preparation of citalopram
06/03/2003CA2140657C Static condition process for the preparation of phosphorus/vanadium oxidation catalyst
06/03/2003CA2053954C Process for the preparation of nitroguanidine derivatives
05/2003
05/30/2003WO2003044007A1 Method for the production of chiral, non-racemic 5-substituted gamma-butyrolactones
05/30/2003WO2003044004A1 Method for the production of a phenolic substance from wood
05/30/2003WO2003043975A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
05/30/2003WO2003043959A1 Method for preparing a composition containing at least an internal dehydrating product of a hydrogenated sugar
05/30/2003WO2003043618A2 Amino diols useful in the treatment of alzheimer's disease
05/30/2003WO2003043578A2 Modulators of rho c activity
05/30/2003WO2003018552A3 Aromatic and heteroaromatic acid halides for synthesizing polyamides
05/30/2003CA2467910A1 Modulators of rho c activity
05/30/2003CA2467798A1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
05/30/2003CA2467476A1 Amino diols useful in the treatment of alzheimer's disease
05/29/2003US20030100777 Process for the co-production of aliphatic diols and cyclic ethers
05/29/2003US20030100771 Method for the production of l-ascorbic acid by lactonisation of 2-keto-l-gulonic acid or s2-keto-l-gulonate esters
05/29/2003US20030100760 Process for preparing unsymmetrical biaryls and alkylated aromatic compounds from arylnitriles
05/29/2003US20030100580 Benzenesulfonamide derivatives; for treatment of cardiovascular disorders
05/29/2003US20030100559 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
05/29/2003US20030100441 Polymerization of olefin
05/28/2003EP1314424A1 Seamless soft capsule preparations containing dihydrobenzofuran derivatives
05/28/2003EP1313724A1 N-heteroarylmethyl-p-phenylendiamine derivatives and compounds containing oxidation colouring agents
05/28/2003EP1313721A2 Non-imidazole aryloxyalkylamines as h3 receptor ligands
05/28/2003EP1313701A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
05/28/2003EP1313693A2 Two-stage process for the hydrogenation of maleic acid to 1,4-butanediol
05/28/2003EP1313490A1 Pharmaceutical composition comprising wikstromol and/or matairesinol, its use as hepatoprotectant and process for their isolation from cedrus deodara
05/28/2003EP0788360B1 Boronic ester and acid compounds, synthesis and uses
05/28/2003CN1420111A Naphthalene alizarin derivatives, preparing method and use thereof
05/28/2003CN1109680C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/28/2003CN1109679C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/28/2003CN1109678C Annona tactone analogue and its use
05/28/2003CN1109544C Beta-alkoxyacrylates against malaria
05/27/2003US6570027 Method of preparing intermediates useful in synthesis of retroviral protease inhibitors
05/27/2003US6570026 Method for producing phthalic anhylic anhydride according to specifications
05/27/2003US6569897 Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
05/27/2003US6569895 Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
05/27/2003US6569894 Arylalkylbenzofuran derivatives as melatonergic agents
05/27/2003US6569882 Viricides; enzyme inhibitors
05/27/2003CA2209391C New heterocyclic biaryl compounds and their use in human or veterinary medicine and in cosmetics
05/22/2003WO2003042202A1 Isobenzofuran derivatives
05/22/2003WO2003042201A1 Hydrogenation of 3,4-tetrahydrofurandiol to tetrahydrofuran
05/22/2003WO2003042200A1 Conversion of tetrahydroxybutane to tetrahydrofuran
05/22/2003WO2003042168A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PHENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042167A1 NOVEL α-OXYGENATED OR α-THIOLATED CARBOXYLIC ACID PENETHYLAMIDE DERIVATIVES
05/22/2003WO2003042135A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
05/22/2003WO2003041728A1 Novel phenyl-propargylether derivatives
05/22/2003WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003WO2002059165A3 Polymerization of olefinic compounds
05/22/2003WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
05/22/2003US20030097028 Distilling a medium containing internal dehydration product to obtain a distillate enriched with this product, purifying; contacting with stabilizing agent; shaping the resulting internal dehydration product of a hydrogenated sugar
05/22/2003US20030096996 Process for producing organotitanium compound and process for addition reaction
05/22/2003US20030096864 Compounds to treat alzheimer's disease
05/22/2003US20030096844 Cannabinoid receptor ligands
05/22/2003US20030096825 Antiviral activity; treatment of HIV and AIDS
05/22/2003US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
05/22/2003US20030096806 For use as pesicides, herbicides; crop protection
05/22/2003US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders
05/22/2003US20030096374 Synthesis of oligoketides
05/22/2003US20030095985 Immunogenic conjugates of Gram-negative bacterial autoinducer molecules and antibodies raised against the same
05/22/2003CA2466449A1 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
05/22/2003CA2466317A1 Hydrogenation of 3,4-tetrahydrofurandiol to tetrahydrofuran
05/22/2003CA2466311A1 Conversion of tetrahydroxybutane to tetrahydrofuran
05/22/2003CA2466115A1 Cyanoalkylamino derivatives as protease inhibitors
05/22/2003CA2464775A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1311499A2 Bicyclic compounds as h3 receptor ligands
1 ... 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 ... 472